Skip to main content
SpringerLink
Log in

Dilatative Kardiomyopathie

  • Chapter
Interventionen am Herzen

  • 33 Accesses

Zusammenfassung

Die dilatative Kardiomyopathie ist eine Erkrankung des Myokards ungeklärter Ursache, die sich in einer eingeschränkten systolischen Funktion des Myokards und in einer Dilatation des Herzens manifestiert. Die Dilatation kann den linken, den rechten oder beide Ventrikel betreffen. Nach dieser WHO-Definition der Kardiomyopathie [38] müssen von diesem Krankheitsbild sekundäre Kardiomyopathien mit geklärter Ätiologie, z. B. ischämische Kardiomyopathien, auf dem Boden einer koronaren Herzkrankheit oder auf dem Boden von Herzklap-penvitien, Kardiomyopathien durch toxische Einflüsse oder bei endokrinen Erkrankungen unterschieden werden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 74.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Archard LC, Bowles NE, Olsen EGJ, Richardson PJ (1987) Detection of persistent Coxsackie B virus RNA in dilated cardiomyopathy and myocarditis. Eur Heart J 8 (Suppl J): 437–440

    Google Scholar 

  2. Archard LC, Bowles NE, Cunningham L et al. (1990) Enterovirus RNA sequences in hearts with dilated cardiomyopathy: a pathogenetic link between virus infection and dilated cardiomyopathy. In: Baroldi G, Cameri F, Goodwin JF (eds) Advances in cardiomyopathies. Springer, Berlin Heidelberg New York Tokyo, pp 194–198

    Google Scholar 

  3. Aretz HT, Billingham ME, Edwards WD et al. (1987) Myocarditis: A histopathological definition and classification. Am J Cardiovasc Pathol 1: 3–14

    PubMed  CAS  Google Scholar 

  4. Bagger JP, Baandrup U, Rasmusen K, Miller M, Vesterlund T (1984) Cardiomyopathy in western Denmark. Br Heart J L 52: 327–331

    Article  CAS  Google Scholar 

  5. Bowles NE, Richardson PJ, Olsen GJ, Archard LC (1986) Detection of Coxsackie B virus-specific RNA sequenes in myocardial samples from patients with myocarditis and dilated cardiomyopathy. Lancet I: 1120–1123

    Article  Google Scholar 

  6. Bowles NE, Rose ML, Taylor P et al. (1989) End-stage dilated cardiomyopathy. Persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation 80: 1128–1136

    Article  PubMed  CAS  Google Scholar 

  7. Caforio ALP, Grazzini M, Mann JM; Keelin PF, Bottazzo GF, McKenna WJ, Schiaffino S (1992) Identification of α- and β-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 85: 1734–1742

    PubMed  CAS  Google Scholar 

  8. DeMaria R, Gavazzi A, Recalcati F, Baroldi G, De Vita C, Cameri F (1993) Comparison of clinical findings in idiopathic dilated cardiomyopathy in women versus men. Am J Cardiol 72: 580–585

    Article  CAS  Google Scholar 

  9. Eckstein R, Mempel W, Boite HD (1982) Reduced suppressor cell activity in congestive cardiomyopathy and in myocarditis. Circulation 59: 1224–1229

    Article  Google Scholar 

  10. Fallon JT (1987) Myocarditis and dilated cardiomyopathy: different stages of the same disease? In: Waller B (ed) Contemporary issues in cardiovascular clinics. 18: 155–162

    Google Scholar 

  11. Figulla H, Rahlf G, Nieger M, Luig H, Kreuzer H (1985) Spontaneous hemodynamic improvement or stabilization and associated biopsy findings in patients with congestive cardiomyopathy. Circulation 71: 1095–1104

    Article  PubMed  CAS  Google Scholar 

  12. Fowles RE (1990) Natural history and prognosis of overt dilated cardiomyopathy. In: Baroldi G, Cameri F, Goodwin JF (eds) Advances in cardiomyopathies. Springer, Berlin Heidelberg New York Tokyo, pp 337–346

    Google Scholar 

  13. Hammond EH, Menlove RL, Anderson JL (1987) Predictive value of immunofluorescence and electron microscopic evaluation of endomyocardial biopsies in the diagnosis and prognosis of myocarditis and idiopathic dilated cardiomyopathy. Am Heart J 114: 1055–1065

    Article  PubMed  CAS  Google Scholar 

  14. Herskowitz A, Neumann DA, Ansari AA (1993) Concepts of autoimmunity applied to idiopathic dilated cardiomyopathy. J Am Coll Cardiol 22: 1385–1388

    Article  PubMed  CAS  Google Scholar 

  15. Keren A, Popp RL (1992) Assignment of patients into the classification of cardiomyopathies. Circulation 86: 1622–1632

    PubMed  CAS  Google Scholar 

  16. Latham RD, Mulrow JP, Virmani R, Robinowitz M, Moody JM (1989) Recently diagnosed idiopathic dilated cardiomyopathy: incidence of myocarditis and efficacy prednisone therapy. Am Heart J 117: 876–882

    Article  PubMed  CAS  Google Scholar 

  17. Latif N, Baker CS, Dunn MJ, Rose ML, Brady P, Yacoub MH (1993) Frequency and specifity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS PAGE and Western blotting. J Am Coll Cardiol 22: 1378–1384

    Article  PubMed  CAS  Google Scholar 

  18. Limas CL, Limas C (1989) HLA antigens in idiopathic dilated cardiomyopathy. Br Heart J 62: 379–383

    Article  PubMed  CAS  Google Scholar 

  19. Limas CL, Limas C, Kubo SH, Olivari MT (1990) Anti-beta-receptor antibodies in human dilated cardiomyopathy and correlation with HLA-DR antigens. Am J Cardiol 65: 483–487

    Article  PubMed  CAS  Google Scholar 

  20. Maisch G, Deeg P, Liebau G, Kochsiek K (1983) Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol 52: 1072–1078

    Article  PubMed  CAS  Google Scholar 

  21. Maisch G, Bauer E, Herzum M, Hufnagel G, Izumi T, Nunoda S, Schönian U (1990) Humoral and cell-mediated immunity: pathogenetic mechanisms in dilated cardiomyopathy. In: In: Baroldi G, Cameri F, Goodwin JF (eds) Advances in cardiomyopathies. Springer, Berlin Heidelberg New York Tokyo, pp 209–220

    Google Scholar 

  22. Manolio TA, Baughman KL, Rodeheffer R et al. (1992) Revalence and etiology of idiopathic dilated cardiomyopathy (summary of a national heart, lung, and blood institute workshop). Am J Cardiol 69: 1458–1466

    Article  PubMed  CAS  Google Scholar 

  23. Massie BM, Schiller NB, Ratchim RA, Parmley WW(1977) Mitral-septal separation: new echocardiographic index of left ventricular function. Am J Cardiol 39: 1008–1016

    Article  PubMed  CAS  Google Scholar 

  24. Michaelis VV, Moll PP, Miller FA et al. (1992) The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 326: 77–82

    Article  Google Scholar 

  25. Morad M, Davies NW, Ulrich G, Schultheiß H-P (1988) Antibodies against ADP-ATP carrier enhance Ca2+ current in isolated cardiac myocytes. Am J Physiol 255: H960–964

    PubMed  CAS  Google Scholar 

  26. Ng KSK, Gibson DG (1990) Relation of diastolic filling pattern to diastolic function in severe left ventricular disease. Br Heart J 63: 209–214

    Article  PubMed  CAS  Google Scholar 

  27. Obrador D, Ballester M, Carrio I, Berna L, Pons-Llado G (1989) High prevalence of myocardital monoclonal anti-myosin antibody uptake in patients with chronic idiopathic dilated cardiomyopathy. J Am Coll Cardiol 13: 1289–1293

    Article  PubMed  CAS  Google Scholar 

  28. O’Connel JB, Henkin RE, Robinson JA, Subramanian R, Scanlon PJ, Gunnar RM (1984) Gallium 67 imaging in patients with dilated cardiomyopathy and biopsy proven myocarditis. Circulation 70: 58–62

    Article  Google Scholar 

  29. Olsen EGJ, Trotter SE (1993) Dilated Cardiomyopathy. Pathology. In: Goodwin J, Olsen E (eds) Cardiomyopathies: Realisations and expectations. Springer, Berlin Heidelberg New York Tokyo, pp 19–26

    Google Scholar 

  30. Parillo E, Cunnion RE, Epstein SE et al. (1989) A prospective randomized controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 321: 1061–1068

    Article  Google Scholar 

  31. Schulze K, Becker BF, Schauer R, Schultheiß HP (1990) Antibodies to ADP-ATP carrier — an autoantigen in myocarditis and dilated cardiomyopathy — impair cardiac function. Circulation 81: 959–969

    Article  PubMed  CAS  Google Scholar 

  32. Schwimmbeck PL, Schultheiß HP, Strauer BE (1990) Identification of a main autoimmunogenic epitope of the adenine nucleotide translocator which cross-reacts with coxsak-kie B3 virus: use in the diagnosis of myocarditis and dilated cardiomyopathy. Circulation 80 (Suppl II): 665

    Google Scholar 

  33. Shah PM (1988) Echocardiography in congestive or dilated cardiomyopathy. J Am Soc Echo 1: 20–30

    CAS  Google Scholar 

  34. Sole MJ, Liu P (1993) Viral myocarditis: a paradigm for understanding the pathogenesis and treatmend of dilated cardiomyopathy. J Am Coll Cardiol 22 (Suppl A): 99A–105A

    Article  PubMed  CAS  Google Scholar 

  35. Tazelaar HD, Billingham ME (1986) Leucocytic infiltrates in idiopathic dilated cardiomyopathy: A source of confusion with active myocarditis. Am J Surg Pathol 10: 405–412

    Article  PubMed  CAS  Google Scholar 

  36. Wallis DE, O’Connell JB, Henkin RE, Costanzo-Nordin MR, Scanlon PJ (1984) Segmental wall motion abnormalities in dilated cardiomyopathy: a common finding and good prognostic sign. J Am Coll Cardiol 4: 674–679

    Article  PubMed  CAS  Google Scholar 

  37. Wallukat G, Morwinski M, Kowal K, Förster A, Boewer V, Wollenberger A (1991) Autoantibodies against the β-adre-nergic receptor in human myocarditis and dilated cardiomyopathy: β-adrenergic agonism without desensitization. Eur Heart J 12 (Suppl D): 178–181

    PubMed  Google Scholar 

  38. WHO/ISFC (1980) Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 44: 672–673

    Article  Google Scholar 

  39. Yasuda TS, Palacios IF, Dec W et al. (1987) Indium-111 monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis. Circulation 76: 306–311

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. S. B. Felix
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Baumann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Herzchirurgie Salzburg, Müllner Hauptstraße 48, A-5020, Salzburg, Österreich

    Felix Unger

  2. Medizinische Klinik, Diakonissenkrankenhaus Mannheim, Akademisches Lehrkrankenhaus der Universität Heidelberg, Speyerer Straße 91-93, D-68163, Mannheim, Deutschland

    Hubert Mörl

  3. Fachpharmakologe DGPT, Am Huhlchen 5, D-55130, Mainz, Deutschland

    Hans Armin Dieterich

  4. School of Medicine, Dpts. of Medicine and Pharmacology, Georgetown University, Washington D.C., USA

    Hans Armin Dieterich

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Felix, S.B., Baumann, G. (1995). Dilatative Kardiomyopathie. In: Unger, F., Mörl, H., Dieterich, H.A. (eds) Interventionen am Herzen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-93558-9_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-93558-9_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-93559-6

  • Online ISBN: 978-3-642-93558-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation